Search results

  1. R

    International ME/CFS Conference 2025 Berlin May 12-13

    But the person asking the question (I believe it was Prof Birgit Sawitzki) said that for autoimmune diseases the side effects are much more benign than with cancer (which is what Fluge was basing his reply on iirc), right?
  2. R

    Study of the effectiveness of immunotropic therapy of Long-COVID-19 patients with type 6 of human herpes virus reactivation, Zubchenko et al., 2024

    Seems like they've had a pilot study beforehand? And a review that seems to address this (haven't read).
  3. R

    Study of the effectiveness of immunotropic therapy of Long-COVID-19 patients with type 6 of human herpes virus reactivation, Zubchenko et al., 2024

    The drug used is also known as Imunovir. I remember some trials for ME in the past? And also that it's very expensive in the US and dirt cheap in Europe. And that a member here had bad results?
  4. R

    Study of the effectiveness of immunotropic therapy of Long-COVID-19 patients with type 6 of human herpes virus reactivation, Zubchenko et al., 2024

    Introduction. After the acute form of COVID-19, 10 to 30% of patients tend to develop a post-covid syndrome or long-COVID-19. Research is actively being conducted into the causes of long-term COVID-19, one of which may be a violation of the immune response after SARS-CoV2 enters the body as a...
  5. R

    International ME/CFS Conference 2025 Berlin May 12-13

    Important to add that he himself showed this data only tentatively. Saying that it might well be chance, but with their small cohort they have seen this correlation. Thus going forward, to more successfully meet endpoints, they will introduce NK cell amount as an inclusion criterion.
  6. R

    International ME/CFS Conference 2025 Berlin May 12-13

    This is baseline, pre treatment. Additionally, in the responder group there were only moderate and moderate/severe patients. The 2 severe patients in this study did not respond.
  7. R

    PEM: A thread for sharing your experience of post-exertional malaise

    Wasn't sure where else to post this, but this Bio-Sig PEM study seems quite comprehensive.
  8. R

    Preprint Dissecting the genetic complexity of myalgic encephalomyelitis/chronic fatigue syndrome via deep learning-powered genome analysis, 2025, Zhang+

    This slide was shared today at the ME/CFS conference in Berlin, on the basis that B cells need T cell (th) signals in order to mature. They thus checked if those signals are changed leading to potential autoimmune processes in pwME. Dubbed "plasma proteome of b/t cell secreted molecules". Very...
  9. R

    Pathophysiology of sleep disturbances/unrefreshing sleep in pwME?

    Here are the screenshots - I hope it's OK to share them here. Papers in preparation it says. So they seem to have seen decreased sleep spindles in long COVID patients. Some potential correlations to ACE2-AAbs and serum MDA. Will be interesting to see the bigger cohort where they will in...
  10. R

    International ME/CFS Conference 2025 Berlin May 12-13

    This is the baseline, could you also share the table they showed for after treatment? I think it even went up to 15000 if I recall correctly?
  11. R

    Pathophysiology of sleep disturbances/unrefreshing sleep in pwME?

    There was just a presentation of the "Sleep-Neuro-Path" study in Germany. More info here. Will share some screenshots of disturbances they found in (if I understood correctly) studies done before this new study. Seem to have found a difference in sleep spindles in NREM2 and will now look deeper...
  12. R

    Pathophysiology of sleep disturbances/unrefreshing sleep in pwME?

    Interesting angle! As an analogy, would you in that case contribute e.g. impaired working memory with running out of RAM to process/save new information? Though the brain surely is more complex than this analogy would make it sound. Do you know in which sleep stage this complement-mediated...
  13. R

    Pathophysiology of sleep disturbances/unrefreshing sleep in pwME?

    Pharmaceutically, I believe there is reasonable evidence for certain drugs to be able to modulate this. Also within the 'inverted u' for sleep microarousals of the Lüthi paper I linked various times. Selectively through deep brain stimulation or something like that, I have no idea of. Drugs...
  14. R

    International ME/CFS Conference 2025 Berlin May 12-13

    Fluge will present "Plasma cell targeting in ME/CFS" in a couple minutes.
  15. R

    International ME/CFS Conference 2025 Berlin May 12-13

    Sounds interesting indeed! Much appreciated!
  16. R

    International ME/CFS Conference 2025 Berlin May 12-13

    I found the immunological block quite interesting today. Has anybody followed it? @Jonathan Edwards maybe?
  17. R

    Lactic acid, lactate in ME/CFS

    For what it's worth, in the PEM conference the other day, I believe three different groups (Putrino, Puta and another one) showed either preliminary or clinical data from their clinics - all of them seeing increased plasma lactate during rest and activity compared to healthy adults. It was...
  18. R

    May 10th 2025: Demystifying PEM MedUni Vienna

    I don't know if the talks were recorded and will be shared.
  19. R

    May 10th 2025: Demystifying PEM MedUni Vienna

    I'm not sure anything new or groundbreaking has been shared. Amongst different clinical or scientific groups, they found an increased active and resting lactate level. Beta 2 receptor involvement (and thus potentially autoantibodies) in exercise-induced lymphocyte migration was mentioned by...
  20. R

    Pathophysiology of sleep disturbances/unrefreshing sleep in pwME?

    I am not hypothesizing that "symptom severity" was due to this. I am questioning the pathophysiology of unrestful sleep and questioning whether this symptom can't be tackled adequately by specifically addressing the differences seen in PSG. Again, if infraslow power and microarousals play a...
Back
Top